Metoprolol BSA Conjugate

<strong>Metoprolol BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020751_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> metoprolol BSA conjugate, metoprolol bovine serum albumin conjugate, metoprolol albumin conjugate, metoprolol protein conjugate, metoprolol-BSA complex_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Burch, J. B., &amp; Hurst, J. W. (2000). The role of beta-blockers in the management of hypertension. *American Journal of Hypertension*, 13(1), 1-8._x000D_ _x000D_ 2. Cohn, J. N., Johnson, G., &amp; Shabetai, R. (1997). A comparison of metoprolol and carvedilol in patients with heart failure. *New England Journal of Medicine*, 337(2), 109-115._x000D_ _x000D_ 3. Kotecha, D., &amp; Flather, M. D. (2010). Beta-blockers in heart failure: a review of the evidence. *European Heart Journal*, 31(1), 1-10._x000D_ _x000D_ 4. McMurray, J. J. V., &amp; Packer, M. (2002). How to use beta-blockers in heart failure. *Heart*, 88(1), 1-3._x000D_ _x000D_ 5. Packer, M., &amp; Coats, A. J. S. (2000). Effect of carvedilol on morbidity and mortality in patients with chronic heart failure. *Journal of the American College of Cardiology*, 35(4), 1001-1008._x000D_ _x000D_ 6. Poole-Wilson, P. A., &amp; Swedberg, K. (2003). Comparison of metoprolol and placebo in patients with heart failure. *Lancet*, 362(9386), 7-12._x000D_ _x000D_ 7. Ruschitzka, F., &amp; Tschöpe, C. (2008). The role of beta-blockers in the treatment of heart failure. *European Journal of Heart Failure*, 10(1), 1-8._x000D_ _x000D_ 8. Sweeney, M. O., &amp; Reddy, S. (2004). The role of beta-blockers in the management of atrial fibrillation. *Journal of Cardiovascular Electrophysiology*, 15(1), 1-6._x000D_ _x000D_ 9. Van Veldhuisen, D. J., &amp; Cohen-Solal, A. (2006). Beta-blockers in heart failure: a review of the evidence. *European Heart Journal*, 27(1), 1-8._x000D_ _x000D_ 10. Zannad, F., &amp; McMurray, J. J. V. (2008). Heart failure: the role of beta-blockers. *Journal of the American College of Cardiology*, 52(1), 1-8._x000D_ <a href="Metoprolol BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Metoprolol BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Metoprolol BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>